We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Liletta, a levonorgestrel-releasing ...
The approval was based on additional efficacy data from the ACCESS IUS trial. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Liletta ® ...
Credit: Getty Images. For the treatment of heavy menstrual bleeding, Liletta should be replaced by the end of the fifth year if continued use is needed. The Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results